While the majority of the mCRPC cohorts were comprised of single tumors from an individual patient, the UW autopsy study included three patients with CDK12BAL where multiple tumors were sampled, allowing for assessments of tumor heterogeneity with respect to CDK12 events. The gene discussed is CDK12; the disease is neoplasm.